Search

Your search keyword '"Koell B"' showing total 44 results

Search Constraints

Start Over You searched for: Author "Koell B" Remove constraint Author: "Koell B"
44 results on '"Koell B"'

Search Results

2. Impact of anaemia and iron deficiency on long-term outcomes following transcatheter edge-to-edge repair in degenerative vs. secondary mitral regurgitation: results from a large single-center study

3. NYHA class IV in patients with degenerative mitral regurgitation undergoing transcatheter edge-to-edge repair: Results of the worldwide, multicenter PRIME-MR registry

5. Left and right ventricular hemodynamic response after transcatheter mitral valve replacement

8. Outcomes of patients with severe mitral regurgitation treated with transcatheter mitral valve implantation or medical therapy

9. Long-Term survival and functional status in patients with elevated mitral valve pressure gradient after transcatheter mitral valve repair

13. P3858High H2FPEF score is an independent predictor of adverse outcome in patients with severe aortic stenosis and preserved ejection fraction undergoing TAVR

16. Atrial Secondary Tricuspid Regurgitation: Insights Into the EuroTR Registry.

17. The prognostic value of the Dandel's index in patients undergoing tricuspid transcatheter edge-to-edge repair.

18. Long-Term Outcomes After Edge-to-Edge Repair of Secondary Mitral Regurgitation: 5-Year Results From the EuroSMR Registry.

19. Impact of Pulmonary Hypertension on Outcomes After Transcatheter Tricuspid Valve Edge-to-Edge Repair.

20. Residual tricuspid regurgitation after tricuspid transcatheter edge-to-edge repair: Insights into the EuroTR registry.

21. Impact of Intraprocedural Mitral Regurgitation and Gradient Following Transcatheter Edge-to-Edge Repair for Primary Mitral Regurgitation.

22. Right Coronary Artery Injury in Transcatheter Annuloplasty for Secondary Tricuspid Regurgitation: A Real-World Multicenter Study.

23. Guideline-Directed Medical Therapy and Survival After TEER for Secondary Mitral Regurgitation With Right Ventricular Impairment.

24. Left and Right Ventricular Hemodynamic Response After Transcatheter Mitral Valve Replacement.

25. Applying the TRILUMINATE Eligibility Criteria to Real-World Patients Receiving Tricuspid Valve Transcatheter Edge-to-Edge Repair.

26. Impact of Transcatheter Edge-to-Edge Mitral Valve Repair on Guideline-Directed Medical Therapy Uptitration.

27. Leaflet Morphology and its Implications for Direct Transcatheter Annuloplasty of Tricuspid Regurgitation.

28. Sex-related characteristics and short-term outcomes of patients undergoing transcatheter tricuspid valve intervention for tricuspid regurgitation.

29. Staging Heart Failure Patients With Secondary Mitral Regurgitation Undergoing Transcatheter Edge-to-Edge Repair.

30. Guideline-directed medical therapy in patients undergoing transcatheter edge-to-edge repair for secondary mitral regurgitation.

31. Reply: Could Left Atrial Function Modify Outcomes After Transcatheter Edge-to-Edge Repair of the Mitral Valve?

32. Left atrial volume index and outcome after transcatheter edge-to-edge valve repair for secondary mitral regurgitation.

33. Management of patients with mitral regurgitation ineligible for standard therapy undergoing TMVI screening.

34. Long-Term Outcomes of Patients With Elevated Mitral Valve Pressure Gradient After Mitral Valve Edge-to-Edge Repair.

35. Outcomes Stratified by Adapted Inclusion Criteria After Mitral Edge-to-Edge Repair.

36. Current devices and interventions in mitral regurgitation.

37. Characteristics and Outcomes of Patients Ineligible for Transcatheter Mitral Valve Replacement (TMVR): Implications for Future Device Innovation.

38. Prognostic value of the H 2 FPEF score in patients undergoing transcatheter aortic valve implantation.

39. Screening for transcatheter mitral valve replacement: a decision tree algorithm.

40. Establishment of an enhanced recovery after surgery protocol in minimally invasive heart valve surgery.

41. Fluid status and outcome in patients with heart failure and preserved ejection fraction.

42. Diastolic Pressure Gradient Predicts Outcome in Patients With Heart Failure and Preserved Ejection Fraction.

43. Outcome in Heart Failure with Preserved Ejection Fraction: The Role of Myocardial Structure and Right Ventricular Performance.

44. Prognostic Significance and Determinants of the 6-Min Walk Test in Patients With Heart Failure and Preserved Ejection Fraction.

Catalog

Books, media, physical & digital resources